Tutorials › Multi-Arm Multi-Stage (MAMS) Designs › Ranking Treatment Arms With a Shared Control

Dropping Arms at Interim Analyses · Tutorial 112 of 499

Ranking Treatment Arms With a Shared Control

You will calculate and interpret treatment-arm rankings when all arms share a control, distinguishing the observed order from uncertainty about pairwise differences.

Advanced 10 min read

What You'll Learn

  • Rank estimated treatment effects when several arms share one control group.
  • Calculate the covariance and correlation induced by the shared control.
  • Derive the standard error for comparing two estimated treatment effects.
  • Interpret pairwise intervals without treating an observed rank as proof of a true rank.
  • Diagnose errors caused by assuming shared-control estimates are independent.

Why Shared-Control Rankings Need Care

At an interim analysis, the estimated treatment effects may provide a useful ordering of the arms. But when every arm is compared with the same control group, those estimates are dependent: a control mean that happens to be low makes all estimated benefits look higher, while a high control mean makes them all look lower. The observed order is still easy to calculate, but interpreting how stable that order is requires accounting for the shared control.

This tutorial focuses on ranking arms using their estimated treatment-control differences and examining the uncertainty in pairwise differences between those estimates. A ranking is descriptive: it orders the estimates in the observed data. It does not, by itself, establish which treatment has the largest true effect or prescribe which arms should continue.

Definition: Let \(\bar X_i\) be the observed mean outcome in treatment arm \(i\), and let \(\bar X_0\) be the observed mean in the common control arm. When higher outcomes are better, the estimated treatment effect for arm \(i\) is \(\hat{\tau}_i=\bar X_i-\bar X_0\). Ranking by estimated effect means ordering the \(\hat{\tau}_i\) values from largest to smallest. If lower outcomes are better, the contrast direction must be reversed consistently.

The calculations below use a simple model: participants in each group are independent, outcomes in every group are normally distributed with a common known variance \(\sigma^2\), and the treatment arms and control are observed on the same outcome scale and at the same assessment time. The sample sizes are fixed. These assumptions let us calculate exact variances and normal-based intervals. In an application, the variance is usually estimated, and the analysis must use the appropriate variance estimator and reference distribution.

How the Shared Control Affects Pairwise Ranks

For two treatment arms \(i\) and \(j\), the difference between their estimated treatment effects is \(\hat{\tau}_i-\hat{\tau}_j=(\bar X_i-\bar X_0)-(\bar X_j-\bar X_0)=\bar X_i-\bar X_j\). The common control mean cancels. Under the stated model, the estimated treatment effects have a shared-control covariance, but the uncertainty in their pairwise difference can be found directly from the two treatment-arm means.

$$ \operatorname{Var}(\hat{\tau}_i)=\sigma^2\left(\frac{1}{n_i}+\frac{1}{n_0}\right), \qquad \operatorname{Cov}(\hat{\tau}_i,\hat{\tau}_j)=\frac{\sigma^2}{n_0}\quad (i\ne j). $$

Here \(n_i\) and \(n_0\) are the sample sizes in treatment arm \(i\) and control. The covariance is positive because both estimates contain \(-\bar X_0\). The resulting correlation is the covariance divided by the product of the two standard errors. It is not generally the same for every pair if treatment sample sizes differ.

$$ \operatorname{Var}(\hat{\tau}_i-\hat{\tau}_j) =\operatorname{Var}(\hat{\tau}_i)+\operatorname{Var}(\hat{\tau}_j) -2\operatorname{Cov}(\hat{\tau}_i,\hat{\tau}_j) =\sigma^2\left(\frac{1}{n_i}+\frac{1}{n_j}\right). $$

The final equality follows by substituting the variances and covariance: the two terms involving \(1/n_0\) cancel. Thus, under this model, uncertainty in the relative effect of two arms depends on their treatment-group sample sizes and outcome variance, not on the control sample size. The control sample size still affects the marginal precision of each treatment-versus-control estimate.

With known \(\sigma\), a pointwise 95% interval for the difference in true effects, \(\tau_i-\tau_j\), is the observed difference \(\hat{\tau}_i-\hat{\tau}_j\) plus or minus \(1.96\) times its standard error. This interval describes uncertainty for that one pairwise comparison; it is not a simultaneous interval for all pairs, nor is it a probability statement about which treatment is truly best.

Worked Example: Ranking Two Arms and Quantifying Their Dependence

Suppose a hypothetical trial measures an outcome for which higher values are better. There are 36 participants in each group, the common known outcome standard deviation is 6 units, and the observed means are 20 units for control, 22 units for treatment A, and 23.5 units for treatment B. Assume independent participants, a common normal outcome variance, equal assessment timing, and the stated sample sizes. These conditions match the model used for the calculations.

The estimated effects are \(\hat{\tau}_A=22-20=2\) units and \(\hat{\tau}_B=23.5-20=3.5\) units. The observed ranking is therefore B above A. Each estimate has variance \(6^2(1/36+1/36)=2\) square units, and their covariance is \(6^2/36=1\) square unit. Their correlation is \(1/\sqrt{2\cdot2}=0.500\).

The estimated difference in effects is \(3.5-2=1.5\) units. Its standard error is \(SE=\sqrt{6^2(1/36+1/36)}=\sqrt{2}=1.414\) units. The pointwise 95% interval is \(1.5\pm1.96\sqrt{2}=[-1.272,\ 4.272]\) units, using unrounded intermediate values.

The estimate ranks B higher in these data, but the interval includes zero and includes differences in either direction. The data do not precisely distinguish the arms’ effects. The interval is about the pairwise effect difference, not about the chance that B is truly better.

A Three-Arm Ranking With a Common Control

With three arms, the same principle applies to every pair. Sorting the three observed effects gives an ordering, while pairwise differences show how uncertain the adjacent and non-adjacent comparisons are. Because the estimates share a control, it would be incorrect to calculate their pairwise difference variance as if the estimates were independent.

Worked Example: Three Arms With Closely Spaced Estimates

Consider a hypothetical, equal-allocation study with 25 participants in control and 25 in each of arms A, B, and C. The observed means are 50.0 units for control, 54.0 for A, 54.2 for B, and 54.5 for C. Assume independent participants, normally distributed outcomes with common known standard deviation 4 units, and a common outcome scale and assessment time. These assumptions justify the normal calculations and the shared-control formulas.

The estimated treatment effects are \(4.0\), \(4.2\), and \(4.5\) units for A, B, and C, respectively. The observed order is C, then B, then A. Each treatment-control estimate has variance \(16(1/25+1/25)=1.28\) square units. The covariance for any pair is \(16/25=0.64\) square units, so each pairwise correlation is \(0.64/1.28=0.500\).

For C versus A, the estimated difference in benefit is \(4.5-4=0.5\) units. Its standard error is \(\sqrt{16/25+16/25}=\sqrt{1.28}=1.131\) units. The pointwise 95% interval is \(0.5\pm1.96\sqrt{1.28}=[-1.717,\ 2.717]\) units. The endpoints use the unrounded standard error: the margin is \(1.96\sqrt{1.28}=2.2174868\), giving endpoints \(-1.7174868\) and \(2.7174868\) before rounding.

For B versus A, the estimated difference is \(4.2-4.0=0.2\) units, with the same standard error. Its pointwise interval is \(0.2\pm1.96\sqrt{1.28}=[-2.017,\ 2.417]\) units. For C versus B, the estimated difference is \(4.5-4.2=0.3\) units, giving \(0.3\pm1.96\sqrt{1.28}=[-1.917,\ 2.517]\) units. All three intervals include zero. Thus the observed ranking is C above B above A, but these data provide weak separation of the estimated effects.

The common control shifts all three estimates together: algebraically, \(\hat{\tau}_C-\hat{\tau}_A=\bar X_C-\bar X_A\). That cancellation is why the pairwise standard error uses the two treatment means alone. It does not make the treatment-control estimates independent; their marginal covariance remains 0.64 square units.

Why the Covariance Calculation Matters

A short derivation makes clear where a common mistake arises. Write each arm’s estimate as its treatment mean minus the common control mean. Since the treatment groups and control are independent, the covariance between the two treatment means and either control mean is zero. The covariance between the estimates therefore comes from the shared control term:

$$ \begin{aligned} \operatorname{Cov}(\bar X_i-\bar X_0,\bar X_j-\bar X_0) &=\operatorname{Cov}(\bar X_i,\bar X_j) -\operatorname{Cov}(\bar X_i,\bar X_0)\\ &\quad-\operatorname{Cov}(\bar X_0,\bar X_j) +\operatorname{Var}(\bar X_0)\\ &=0-0-0+\frac{\sigma^2}{n_0} =\frac{\sigma^2}{n_0}. \end{aligned} $$

Subtracting twice this covariance is essential when calculating the variance of the difference between two estimates. Omitting it incorrectly adds the shared-control variation twice instead of allowing it to cancel. Under unequal treatment sample sizes, the pairwise formula remains \(\sigma^2(1/n_i+1/n_j)\) in this equal-variance model, even though the marginal standard errors and correlations differ by arm.

Worked Example: Unequal Treatment Sample Sizes

Suppose a hypothetical trial has 40 control participants, 20 participants in A, and 80 in B. The observed means are 100 units for control, 104 for A, and 103.5 for B. Assume independent participants, normally distributed outcomes with common known standard deviation 10 units, and the same outcome scale and timing in all groups. These assumptions permit use of the common-variance formulas, while the unequal sample sizes must be retained in each calculation.

The estimated effects are 4 units for A and 3.5 units for B, so A ranks above B by 0.5 units. The marginal variances are \(100(1/20+1/40)=7.5\) square units for A and \(100(1/80+1/40)=3.75\) square units for B. The covariance is \(100/40=2.5\) square units, giving correlation \(2.5/\sqrt{7.5(3.75)}=0.471\) to three significant figures.

The pairwise difference standard error is \(\sqrt{100(1/20+1/80)}=\sqrt{6.25}=2.5\) units. The pointwise 95% interval for A minus B is \(0.5\pm1.96(2.5)=[-4.400,\ 5.400]\) units. Equivalently, combining marginal variances and covariance gives \(7.5+3.75-2(2.5)=6.25\) square units. The observed ordering is A above B, but the interval is broad and includes differences favoring either arm.

Diagnostics, Alternatives, and Limitations

Before interpreting a rank, check that all estimates use the same outcome scale, contrast direction, and assessment time. If effects are reported with mixed directions—for example, a lower value is favorable for one outcome but a higher value is favorable for another—convert them to a consistent direction before sorting. Also verify the sample sizes and variance assumptions used for the uncertainty calculation. If group variances differ, the equal-variance formulas above are not appropriate without modification.

A frequent error is to treat the treatment-control estimates as independent and calculate the variance of their difference by simply adding their marginal variances. That calculation gives \(\sigma^2(1/n_i+1/n_0)+\sigma^2(1/n_j+1/n_0)\), which incorrectly retains two control-variance terms. The correct calculation subtracts twice the covariance, \(\sigma^2/n_0\), leaving \(\sigma^2(1/n_i+1/n_j)\). Another error is to say, “C ranked first, so C is the best treatment.” The observed order describes the point estimates; it is not proof of the true ordering.

Ranking point estimates is simple and remains meaningful as a description of the observed data. Pairwise differences with standard errors or intervals add information about precision. An alternative design with separate control groups for each treatment would not have this same shared-control covariance, but would use control data differently and generally require more control participants to achieve comparable precision. In either design, rankings alone do not resolve uncertainty or account for all features that may matter to an interim decision.

Pairwise intervals also have limitations. The intervals above are pointwise, not adjusted to provide simultaneous coverage for all comparisons. Overlapping intervals are not a formal test that two effects are equal, and an interval including zero does not make the observed ranking disappear. Conversely, a precise ordering in one interim data set does not guarantee that the ordering will persist with additional data. The appropriate interpretation is narrower: state the estimated order, quantify uncertainty in relevant pairwise differences, and avoid claiming more than those calculations support.

Key takeaway: Rank the shared-control treatment-effect estimates by their observed values, but account for their covariance when assessing pairwise uncertainty. The common control induces positive dependence in the estimates, and its contribution cancels from a pairwise difference under the stated model.

Check Your Understanding

Answer each question using the assumptions stated in the tutorial. Short solutions follow the questions.

  1. Three treatment arms share the same control. What determines their observed ranking by estimated effect?
  2. Under the equal-variance model, why is the covariance between two treatment-control estimates positive?
  3. For equal sample sizes \(n_i=n_j=30\) and known \(\sigma=5\), calculate the standard error of the estimated difference between two treatment effects.
  4. In a shared-control comparison, an analyst adds the two marginal variances and ignores covariance. What is wrong with this method?
  5. An arm has the largest observed estimated effect, but its pairwise interval against another arm includes zero. What can and cannot be concluded?

Solutions. (1) Sort the observed values of \(\hat{\tau}_i=\bar X_i-\bar X_0\) from largest to smallest, using a consistent direction in which higher is better. (2) Both estimates subtract the same random control mean, so their covariance includes \(\operatorname{Var}(\bar X_0)=\sigma^2/n_0>0\). (3) The standard error is \(\sqrt{25(1/30+1/30)}=\sqrt{5/3}=1.291\) units. (4) The calculation omits the subtraction of twice the shared covariance, thereby counting common control variation as if it were independent in the two estimates. (5) One may report that the arm ranked highest in the observed estimates. The interval including zero means the pairwise data do not establish a difference in either direction at the corresponding pointwise level; it does not show that the treatments are equal or give the probability that either is truly best.

Clinical Biostats